Adenoid Cystic Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-02-10
Clinical Trial Update: The Evaluation of the Effectiveness, Safety and Tolerability of Treatment, Using a PSMA-Lu177, in Patients with ACC- an Open, Non-commercial Clinical Trial [Phase 2]
An open Phase 2 trial evaluating PSMA-Lu177 for adenoid cystic carcinoma has been withdrawn.